content ed net

GLOBAL SITE 資料請求

Published Articles

List of published articles

  • Evaluation of combination treatment with DS‑1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR‑mutant non‑small cell lung cancer: results from a multicenter, open‑label phase 1 study

    Source: Invest New Drugs. 2023 Apr;41(2):306-316.
    DOI: https://link.springer.com/article/10.1007/s10637-023-01341-y

  • Phase 1 study of DS-1205c combined with gefitinib for EGFR mutation-positive non-small cell lung cancer

    Source: Cancer Med. 2023 Mar;12(6):7090-7104.
    DOI: https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.5508

  • 日本におけるフォーミュラリーの現状と医薬品の多面的な価値の評価(Current Status of Formulary in Japan and the Assessment of Various Value Components of Medicines)

    Source: YAKUGAKU ZASSHI 142 (12), 1379-1390 (2022)
    DOI: https://www.jstage.jst.go.jp/article/yakushi/142/12/142_22-00127/_article/-char/ja

  • Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan

    Source: Expert Rev Gastroenterol Hepatol. 2022 Aug;16(8):809-817.
    DOI: https://www.tandfonline.com/doi/abs/10.1080/17474124.2022.2114455